FGFR3 and plasma cell myeloma: Translocations bring different oncogenes (such as Cyclin D1 (CCND1), CCND3, fibroblast growth factor receptor 3 (FGFR3), multiple myeloma SET-domain (MMSET/WHSC1), MAF or MAFB) under the control of the IgH enhancer [23].